You are on Trendlyne United States. Click here to go to India website or make United States as your default

Lamond A. David's Insider Trades & SAST Disclosures

Lamond A. David's most recent trade in Quince Therapeutics Inc was a trade of 47,587 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Quince Therapeutics Inc
David A. Lamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 47,587 47,587 - - Director Stock Option (right to buy)
Quince Therapeutics Inc
David A. Lamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 27,000 27,000 - - Employee Stock Option (right to buy)
Quince Therapeutics Inc
David Lamond A. Director Purchase of securities on an exchange or from another person at price $ 1.04 per share. 12 Dec 2023 22,627 2,347,545 (7%) 0% 1.0 23,532 Common Stock
Quince Therapeutics Inc
A. David Lamond Director Purchase of securities on an exchange or from another person at price $ 1.00 per share. 12 Dec 2023 22,627 2,324,918 (7%) 0% 1 22,627 Common Stock
Quince Therapeutics Inc
A. David Lamond Director Purchase of securities on an exchange or from another person at price $ 1.02 per share. 12 Dec 2023 22,327 2,302,291 (7%) 0% 1.0 22,774 Common Stock
Quince Therapeutics Inc
A. Lamond David Director Purchase of securities on an exchange or from another person at price $ 1.00 per share. 12 Dec 2023 300 2,279,964 (7%) 0% 1 300 Common Stock
Quince Therapeutics Inc
David Lamond A. Director Purchase of securities on an exchange or from another person at price $ 1.02 per share. 05 Dec 2023 19,123 2,260,541 (7%) 0% 1.0 19,505 Common Stock
Quince Therapeutics Inc
Lamond A. David Director Purchase of securities on an exchange or from another person at price $ 1.01 per share. 05 Dec 2023 19,123 2,279,664 (7%) 0% 1.0 19,314 Common Stock
Quince Therapeutics Inc
A. Lamond David Director Purchase of securities on an exchange or from another person at price $ 1.01 per share. 05 Dec 2023 19,123 2,241,418 (7%) 0% 1.0 19,314 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 1.32 per share. 30 Aug 2023 41,026 2,179,161 (7%) 0% 1.3 54,154 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 1.31 per share. 30 Aug 2023 41,026 2,138,135 (7%) 0% 1.3 53,744 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 1.29 per share. 15 Aug 2023 117,348 2,072,343 (7%) 0% 1.3 151,379 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 1.32 per share. 15 Aug 2023 107,886 1,954,995 (6%) 0% 1.3 142,410 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 1.29 per share. 15 Aug 2023 24,766 2,097,109 (7%) 0% 1.3 31,948 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2023 27,000 27,000 - - Stock Option (right to buy)
Quince Therapeutics Inc
David A. Lamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 27,000 27,000 - - Stock Option (right to buy)
Applied Molecular Transpor...
David A. Lamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 20,000 20,000 - - Stock Option (Right to Buy)
Applied Molecular Transpor...
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 3.26 per share. 20 May 2022 33,500 1,077,519 - 3.3 109,210 Common Stock
Applied Molecular Transpor...
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 3.08 per share. 20 May 2022 33,000 1,044,019 - 3.1 101,640 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 200,002 1,734,722 (5%) 0% - Common Stock
Quince Therapeutics Inc
David A. Lamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 11,029 11,029 - - Stock Option (right to buy)
Applied Molecular Transpor...
David A. Lamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 15,175 15,175 - - Stock Option (Right to Buy)
Applied Molecular Transpor...
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 42.00 per share. 06 Apr 2021 25,000 1,011,019 - 42 1,050,000 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 33.77 per share. 24 Mar 2021 50,000 1,847,109 (6%) 0% 33.8 1,688,500 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Gift of securities by or to the insider at price $ 0.00 per share. 04 Mar 2021 1,534,720 1,534,720 (5%) 5% 0 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 34.28 per share. 04 Mar 2021 16,621 1,763,730 (6%) 0% 34.3 569,768 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 36.34 per share. 04 Mar 2021 15,969 1,793,009 (6%) 0% 36.3 580,313 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 35.00 per share. 04 Mar 2021 13,310 1,777,040 (6%) 0% 35 465,850 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 36.86 per share. 04 Mar 2021 4,100 1,797,109 (6%) 0% 36.9 151,126 Common Stock
Applied Molecular Transpor...
David A. Lamond None 09 Jun 2020 914,589 914,589 - - Common Stock
Applied Molecular Transpor...
David A. Lamond None Grant, award, or other acquisition of securities at price $ 14.00 per share. 09 Jun 2020 71,430 986,019 - 14 1,000,020 Common Stock
Applied Molecular Transpor...
David A. Lamond None 09 Jun 2020 1 0 - - Series B Preferred Stock
Applied Molecular Transpor...
David A. Lamond None 09 Jun 2020 1 0 - - Series A Preferred Stock
Applied Molecular Transpor...
David A. Lamond None 09 Jun 2020 1 0 - - Series C Preferred Stock
Quince Therapeutics Inc
David A. Lamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 11,029 11,029 - - Stock Option (Right to Buy)
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 43.88 per share. 04 Jun 2020 24,874 1,747,109 (5%) 0% 43.9 1,091,384 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 42.13 per share. 04 Jun 2020 13,609 1,711,593 (5%) 0% 42.1 573,377 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 43.32 per share. 04 Jun 2020 10,642 1,722,235 (5%) 0% 43.3 461,034 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 56.42 per share. 15 May 2020 32,894 1,697,984 (5%) 0% 56.4 1,855,738 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 55.42 per share. 15 May 2020 5,906 1,665,090 (5%) 0% 55.4 327,309 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 48.96 per share. 15 May 2020 1,600 1,657,184 (5%) 0% 49.0 78,333 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 46.30 per share. 15 May 2020 1,263 1,654,599 (5%) 0% 46.3 58,478 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 50.71 per share. 15 May 2020 1,000 1,658,184 (5%) 0% 50.7 50,707 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 48.37 per share. 15 May 2020 985 1,655,584 (5%) 0% 48.4 47,640 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 52.20 per share. 15 May 2020 500 1,658,684 (5%) 0% 52.2 26,101 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 54.09 per share. 15 May 2020 400 1,659,184 (5%) 0% 54.1 21,636 Common Stock
Quince Therapeutics Inc
David A. Lamond Director Purchase of securities on an exchange or from another person at price $ 53.10 per share. 15 May 2020 100 1,658,784 (5%) 0% 53.1 5,310 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades